Hemoglobin (Hb) is the major oxygen (O2)-carrying system of the blood but has many potentially dangerous side effects due to oxidation and reduction reactions of the heme-bound iron and O2. Extracellular Hb, resulting from hemolysis or exogenous infusion, is shown to be an important pathogenic factor in a growing number of diseases. This review briefly outlines the oxidative/reductive toxic reactions of Hb and its metabolites. It also describes physiological protection mechanisms that have evolved against extracellular Hb, with a focus on the most recently discovered: the heme- and radical-binding protein α1-microglobulin (A1M). This protein is found in all vertebrates, including man, and operates by rapidly clearing cytosols and extravascular fluids of heme groups and free radicals released from Hb. Five groups of pathological conditions with high concentrations of extracellular Hb are described: hemolytic anemias and transfusion reactions, the pregnancy complication pre-eclampsia, cerebral intraventricular hemorrhage of premature infants, chronic inflammatory leg ulcers, and infusion of Hb-based O2 carriers as blood substitutes. Finally, possible treatments of these conditions are discussed, giving a special attention to the described protective effects of A1M. Antioxid. Redox Signal. 17, 813–846.
AbrahamNG, KappasA. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev, 60:79–127. 2008.
2.
AckermanZ, SeidenbaumM, LoewenthalE, RubinowA. Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease. Arch Dermatol, 124:1376–1378. 1988.
Afzal-AhmedI, MannGE, ShennanAH, PostonL, NaftalinRJ. Preeclampsia inactivates glucose-6-phosphate dehydrogenase and impairs the redox status of erythrocytes and fetal endothelial cells. Free Radic Biol Med, 42:1781–1790. 2007.
6.
AgrenMS, EaglsteinWH, FergusonMW, HardingKG, MooreK, Saarialho-KereUK, SchultzGS. Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol Suppl (Stockh), 210:3–17. 2000.
7.
AlayashAI. Haptoglobin: old protein with new functions. Clin Chim Acta, 412:493–498. 2011.
8.
AllhornM, BerggårdT, NordbergJ, OlssonML, ÅkerströmB. Processing of the lipocalin α1-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood, 99:1894–1901. 2002.
9.
AllhornM, KlapytaA, ÅkerströmB. Redox properties of the lipocalin α1-microglobulin: reduction of cytochrome c, hemoglobin, and free iron. Free Radic Biol Med, 38:557–567. 2005.
10.
AllhornM, LundqvistK, SchmidtchenA, AkerstromB. Heme-scavenging role of alpha1-microglobulin in chronic ulcers. J Invest Dermatol, 121:640–646. 2003.
11.
AllhornM, CollinM. Sugar-free antibodies–the bacterial solution to autoimmunity?Ann NY Acad Sci, 1173:664–669. 2009.
12.
AltrudaF, PoliV, RestagnoG, ArgosP, CorteseR, SilengoL. The primary structure of human hemopexin deduced from cDNA sequence: evidence for internal, repeating homology. Nucleic Acids Res, 13:3841–3859. 1985.
13.
AmoresanoA, MinchiottiL, CosulichME, CampagnoliM, PucciP, AndolfoA, GianazzaE, GallianoM. Structural characterization of the oligosaccharide chains of human alpha1-microglobulin from urine and amniotic fluid. Eur J Biochem, 267:2105–2112. 2000.
14.
AnX, MohandasN. Disorders of red cell membrane. Br J Haematol, 141:367–375. 2008.
AndersonUD, OlssonMG, RutardóttirS, CentlowM, KristensenKH, IsbergPE, ThilaganathanB, ÅkerströmB, HanssonSR. Fetal hemoglobin and α1-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia. Am J Obstet Gynecol, 204:520e1–520 e5. 2011.
17.
ApplegateLA, LuscherP, TyrrellRM. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res, 51:974–978. 1991.
18.
ArnerES, HolmgrenA. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem, 267:6102–6109. 2000.
19.
ArnholdJ. Properties, functions, and secretion of human myeloperoxidase. Biochemistry (Mosc), 69:4–9. 2004.
20.
ArnholdJ, FlemmigJ. Human myeloperoxidase in innate and acquired immunity. Arch Biochem Biophys, 500:92–106. 2010.
Axt-FliednerR. Second trimester uterine artery Doppler ultrasound as a screening test for adverse pregnancy outcome. Clin Exp Obstet Gynecol, 31:9–11. 2004.
23.
AzarovI, HeX, JeffersA, BasuS, UcerB, HantganRR, LevyA, Kim-ShapiroDB. Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide, 18:296–302. 2008.
24.
Babiker-MohamedH, OlssonML, BoketoftA, LögdbergL, ÅkerströmB. α1-microglobulin is mitogenic to human peripheral blood lymphocytes. Regulation by both enhancing and suppressive serum factors. Immunobiology, 180:221–234. 1990.
25.
Babiker-MohamedH, ÅkerströmB, LögdbergL. Mitogenic effect of alpha-1-microglobulin on mouse lymphocytes. Evidence of T- and B-cell cooperation, B-cell proliferation, and a low-affinity receptor on mononuclear cells. Scand J Immunol, 32:37–44. 1990.
26.
BakerHM, AndersonBF, BakerEN. Dealing with iron: common structural principles in proteins that transport iron and heme. Proc Natl Acad Sci U S A, 100:3579–3583. 2003.
27.
BallaG, JacobHS, EatonJW, BelcherJD, VercellottiGM. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb, 11:1700–1711. 1991.
28.
Baudin-CreuzaV, ChauvierreC, DominguesE, KigerL, LeclercL, VasseurC, CelierC, MardenMC. Octamers and nanoparticles as hemoglobin based blood substitutes. Biochim Biophys Acta, 1784:1448–1453. 2008.
29.
BerggårdT, EnghildJJ, BadveS, SalafiaCM, LögdbergL, ÅkerströmB. Histologic distribution and biochemical properties of α1-microglobulin in human placenta. Am J Reprod Immunol, 41:52–60. 1999.
30.
BerggårdT, OuryTD, ThogersenIB, ÅkerströmB, EnghildJJ. α1-microglobulin is found both in blood and in most tissues. J Histochem Cytochem, 46:887–894. 1998.
31.
BerggårdT, ThelinN, FalkenbergC, EnghildJJ, ÅkerströmB. Prothrombin, albumin and immunoglobulin A form covalent complexes with α1-microglobulin in human plasma. Eur J Biochem, 245:676–683. 1997.
32.
BianY, RongZ, ChangTM. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Artif Cells Blood Substit Immobil Biotechnol, 39:127–136. 2011.
33.
BorettiFS, BuehlerPW, D'AgnilloF, KlugeK, GlausT, ButtOI, JiaY, GoedeJ, PereiraCP, MaggioriniM, SchoedonG, AlayashAI, SchaerDJ. Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. J Clin Invest, 119:2271–2280. 2009.
34.
BouicP, KanitakisJ, SchmittD, VincentC, RevillardJP, ThivoletJ. Alpha 1-microglobulin: a new antigenic component of the epidermo-dermal junction in normal human skin. Br J Dermatol, 112:35–41. 1985.
35.
BouicP, VincentC, RevillardJP. Localization of alpha 1-microglobulin (HC protein) in normal human tissues: an immunohistochemical study using monoclonal antibodies. Histochem J, 16:1311–1324. 1984.
36.
BragginsPE, TrakshelGM, KuttyRK, MainesMD. Characterization of two heme oxygenase isoforms in rat spleen: comparison with the hematin-induced and constitutive isoforms of the liver. Biochem Biophys Res Commun, 141:528–533. 1986.
37.
BratosinD, MazurierJ, TissierJP, EstaquierJ, HuartJJ, AmeisenJC, AminoffD, MontreuilJ. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie, 80:173–195. 1998.
38.
BrattT, CedervallT, ÅkerströmB. Processing and secretion of rat α1-microglobulin-bikunin expressed in eukaryotic cell lines. FEBS Lett, 354:57–61. 1994.
39.
BrattT, OlssonH, SjöbergEM, JergilB, ÅkerströmB. Cleavage of the α1-microglobulin-bikunin precursor is localized to the Golgi apparatus of rat liver cells. Biochim Biophys Acta, 1157:147–154. 1993.
40.
BrittenhamGM. Iron-chelating therapy for transfusional iron overload. N Engl J Med, 364:146–156. 2011.
41.
BrosensJJ, PijnenborgR, BrosensIA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies. Am J Obstet Gynecol, 187:1416–1423. 2002.
42.
Broughton PipkinF. What is the place of genetics in the pathogenesis of pre-eclampsia?Biol Neonate, 76:325–330. 1999.
43.
BrouwerA, GroenendaalF, van HaastertIL, RademakerK, HanloP, de VriesL. Neurodevelopmental outcome of preterm infants with severe intraventricular hemorrhage and therapy for post-hemorrhagic ventricular dilatation. J Pediatr, 152:648–654. 2008.
44.
BruceLJ. Red cell membrane transport abnormalities. Curr Opin Hematol, 15:184–190. 2008.
45.
BucciE, KwansaH, KoehlerRC, MathesonB. Development of zero-link polymers of hemoglobin, which do not extravasate and do not induce pressure increases upon infusion. Artif Cells Blood Substit Immobil Biotechnol, 35:11–18. 2007.
46.
BuehlerPW, AbrahamB, VallelianF, LinnemayrC, PereiraCP, CipolloJF, JiaY, MikolajczykM, BorettiFS, SchoedonG, AlayashAI, SchaerDJ. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood, 113:2578–2586. 2009.
47.
BuehlerPW, D'AgnilloF. Toxicological consequences of extracellular hemoglobin: biochemical and physiological perspectives. Antioxid Redox Signal, 12:275–291. 2010.
48.
BuehlerPW, VallelianF, MikolajczykMG, SchoedonG, SchweizerT, AlayashAI, SchaerDJ. Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways. Antioxid Redox Signal, 10:1449–1462. 2008.
49.
BuehlerPW, ZhouY, CabralesP, JiaY, SunG, HarrisDR, TsaiAG, IntagliettaM, PalmerAF. Synthesis, biophysical properties and pharmacokinetics of ultrahigh molecular weight tense and relaxed state polymerized bovine hemoglobins. Biomaterials, 31:3723–3735. 2010.
50.
BunnH. Hemoglobin. VCH Weinheim, 1992.
51.
BylundJ, BrownKL, MovitzC, DahlgrenC, KarlssonA. Intracellular generation of superoxide by the phagocyte NADPH oxidase: how, where, and what for?Free Radic Biol Med, 49:1834–1845. 2010.
CaleroM, EscribanoJ, GrubbA, MendezE. Location of a novel type of interpolypeptide chain linkage in the human protein HC-IgA complex (HC-IgA) and identification of a heterogeneous chromophore associated with the complex. J Biol Chem, 269:384–389. 1994.
55.
CamejoG, HalbergC, Manschik-LundinA, Hurt-CamejoE, RosengrenB, OlssonH, HanssonGI, ForsbergGB, YlhenB. Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages. J Lipid Res, 39:755–766. 1998.
56.
CentlowM, CarninciP, NemethK, MezeyE, BrownsteinM, HanssonSR. Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes. Fertil Steril, 90:1834–1843. 2008.
57.
CentlowM, WingrenC, BorrebaeckC, BrownsteinMJ, HanssonSR. Differential gene expression analysis of placentas with increased vascular resistance and pre-eclampsia using whole-genome microarrays. J Pregnancy, 2011:472354. 2011.
58.
ChanP, SalierJP. Mouse alpha-1-microglobulin/bikunin precursor: cDNA analysis, gene evolution and physical assignment of the gene next to the orosomucoid locus. Biochim Biophys Acta, 1174:195–200. 1993.
59.
ChangTM. Future generations of red blood cell substitutes. J Intern Med, 253:527–535. 2003.
60.
ChangTM. Blood substitutes based on nanobiotechnology. Trends Biotechnol, 24:372–377. 2006.
61.
ChelikaniP, FitaI, LoewenPC. Diversity of structures and properties among catalases. Cell Mol Life Sci, 61:192–208. 2004.
62.
ChenJY, ScerboM, KramerG. A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. Clinics (Sao Paulo), 64:803–813. 2009.
63.
ChenL, MaoSJ, LarsenWJ. Identification of a factor in fetal bovine serum that stabilizes the cumulus extracellular matrix. A role for a member of the inter-alpha-trypsin inhibitor family. J Biol Chem, 267:12380–12386. 1992.
64.
CimenMY. Free radical metabolism in human erythrocytes. Clin Chim Acta, 390:1–11. 2008.
65.
ColeRH, VandegriffKD. MP4, a vasodilatory PEGylated hemoglobin. Adv Exp Med Biol, 701:85–90. 2011.
66.
CooperCE. Radical Reactions of Haem Proteins. London: BMJ Books/Intensive Care Society, 2002; 66–79.
67.
CooperCE, PatelRP, BrookesPS, Darley-UsmarVM. Nanotransducers in cellular redox signaling: modification of thiols by reactive oxygen and nitrogen species. Trends Biochem Sci, 27:489–492. 2002.
68.
DaviesCE, WilsonMJ, HillKE, StephensP, HillCM, HardingKG, ThomasDW. Use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen, 9:332–340. 2001.
69.
DaviesKJ. Protein damage and degradation by oxygen radicals. I. general aspects. J Biol Chem, 262:9895–9901. 1987.
70.
de Albuquerque WobetoVP, ZaccariottoTR, SonatiMF. Polymorphism of human haptoglobin and its clinical importance. Genet Mol Biol, 31:602–620. 2008.
71.
de GrootCJM, TaylorRN. New Insights into the etiology of pre-eclampsia. Ann Med, 25:243–249. 1993.
72.
DelangheJR, LangloisMR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta, 312:13–23. 2001.
73.
DelaunayJ. The molecular basis of hereditary red cell membrane disorders. Blood Rev, 21:1–20. 2007.
74.
DeMarsDD, KatzmannJA, KimlingerTK, CaloreJD, TracyRP. Simultaneous measurement of total and IgA-conjugated alpha-1-microglobulin by a combined immunoenzyme/immunoradiometric assay technique. Clin Chem, 35:766–772. 1989.
Diarra-MehrpourM, BourguignonJ, SesboueR, MatteiMG, PassageE, SalierJP, MartinJP. Human plasma inter-alpha-trypsin inhibitor is encoded by four genes on three chromosomes. Eur J Biochem, 179:147–154. 1989.
77.
Diarra-MehrpourM, BourguignonJ, SesboueR, SalierJP, LeveillardT, MartinJP. Structural analysis of the human inter-alpha-trypsin inhibitor light-chain gene. Eur J Biochem, 191:131–139. 1990.
78.
DrogeW. Free radicals in the physiological control of cell function. Physiol Rev, 82:47–95. 2002.
79.
DuleyL. Pre-eclampsia, eclampsia, and hypertension. Clin Evid (Online), pii:1402. 2011.
80.
EglerRA, FernandesE, RothermundK, SereikaS, de Souza-PintoN, JarugaP, DizdarogluM, ProchownikEV. Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1. Oncogene, 24:8038–8050. 2005.
81.
EisensteinRS, Garcia-MayolD, PettingellW, MunroHN. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci U S A, 88:688–692. 1991.
82.
EkströmB, BerggårdI. Human α1-microglobulin. Purification procedure, chemical and physiochemical properties. J Biol Chem, 252:8048–8057. 1977.
83.
EscribanoJ, GrubbA, CaleroM, MendezE. The protein HC chromophore is linked to the cysteine residue at position 34 of the polypeptide chain by a reduction-resistant bond and causes the charge heterogeneity of protein HC. J Biol Chem, 266:15758–15763. 1991.
84.
EstepT, BucciE, FarmerM, GreenburgG, HarringtonJ, KimHW, KleinH, MitchellP, NemoG, OlsenK, PalmerA, ValeriCR, WinslowR. Basic science focus on blood substitutes: a summary of the NHLBI Division of Blood Diseases and Resources Working Group Workshop, March 1, 2006. Transfusion, 48:776–782. 2008.
85.
EverseJ, HsiaN. The toxicities of native and modified hemoglobins. Free Radic Biol Med, 22:1075–1099. 1997.
86.
FaberHR, GroomCR, BakerHM, MorganWT, SmithA, BakerEN. 1.8 A crystal structure of the C-terminal domain of rabbit serum haemopexin. Structure, 3:551–559. 1995.
87.
FalangaV, KirsnerR, KatzMH, GouldE, EaglsteinWH, McFallsS. Pericapillary fibrin cuffs in venous ulceration. Persistence with treatment and during ulcer healing. J Dermatol Surg Oncol, 18:409–414. 1992.
88.
FalkenbergC, EnghildJJ, ThogersenIB, SalvesenG, ÅkerströmB. Isolation and characterization of fibronectin-α1-microglobulin complex in rat plasma. Biochem J, 301,Pt 3:745–751. 1994.
89.
FalkenbergC, GrubbA, ÅkerströmB. Isolation of rat serum α1-microglobulin. Identification of a complex with alpha 1-inhibitor-3, a rat alpha 2-macroglobulin homologue. J Biol Chem, 265:16150–16157. 1990.
90.
Fernandez-LunaJL, Leyva-CobianF, MollinedoF. Identification of the protein HC receptor. FEBS Lett, 236:471–474. 1988.
91.
FibachE, RachmilewitzE. The role of oxidative stress in hemolytic anemia. Curr Mol Med, 8:609–619. 2008.
92.
FlowerDR. The lipocalin protein family: structure and function. Biochem J, 318,Pt 1:1–14. 1996.
93.
ForgetBH, HiggsDR. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. New York: Cambridge University Press, 2009.
94.
FriesE, BlomAM. Bikunin—not just a plasma proteinase inhibitor. Int J Biochem Cell Biol, 32:125–137. 2000.
95.
FujitaT, TodaK, KarimovaA, YanSF, NakaY, YetSF, PinskyDJ. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med, 7:598–604. 2001.
96.
FukaiT, Ushio-FukaiM. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal, 15:1583–1606. 2011.
97.
FutagiY, SuzukiY, ToribeY, NakanoH, MorimotoK. Neurodevelopmental outcome in children with posthemorrhagic hydrocephalus. Pediatr Neurol, 33:26–32. 2005.
98.
FutagiY, ToribeY, OgawaK, SuzukiY. Neurodevelopmental outcome in children with intraventricular hemorrhage. Pediatr Neurol, 34:219–224. 2006.
99.
GanforninaL, SanchezD, GreeneLH, FlowerDR. The lipocalin protein family. Protein sequence, structure and relationship to calycin superfamily. Lipocalins. ÅkerströmB, BorregaardN, FlowerDR, SalierJP. Georgetown, TX: Landes Bioscience, 2006; 17–27.
GoswamiT, RolfsA, HedigerMA. Iron transport: emerging roles in health and disease. Biochem Cell Biol, 80:679–689. 2002.
104.
GoyalMM, BasakA. Human catalase: looking for complete identity. Protein Cell, 1:888–897. 2010.
105.
GozzelinoR, JeneyV, SoaresMP. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol, 50:323–354. 2010.
106.
GrangerJP, AlexanderBT, BennettWA, KhalilRA. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens, 14:178S–185S. 2001.
107.
GraversenJH, MadsenM, MoestrupSK. CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol, 34:309–314. 2002.
108.
GreyM, YainoyS, PrachayasittikulV, BulowL. A superoxide dismutase-human hemoglobin fusion protein showing enhanced antioxidative properties. FEBS J, 276:6195–6203. 2009.
109.
GrinbergLN, O'BrienPJ, HrkalZ. The effects of heme-binding proteins on the peroxidative and catalatic activities of hemin. Free Radic Biol Med, 27:214–219. 1999.
110.
GrubbA, MendezE, Fernandez-LunaJL, LopezC, MihaescoE, VaermanJP. The molecular organization of the protein HC-IgA complex (HC-IgA)J Biol Chem, 261:14313–14320. 1986.
111.
GrubbAO, LopezC, TejlerL, MendezE. Isolation of human complex-forming glycoprotein, heterogeneous in charge (protein HC), and its IgA complex from plasma. Physiochemical and immunochemical properties, normal plasma concentration. J Biol Chem, 258:14698–14707. 1983.
112.
GutteridgeJM. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta, 917:219–223. 1987.
113.
HalliwellB, GutteridgeJM. The definition and measurement of antioxidants in biological systems. Free Radic Biol Med, 18:125–126. 1995.
114.
HalliwellB, GutteridgeJMC. Free Radicals in Biology and Medicine, 4th. Oxford University Press: Oxford, 2007.
115.
HanleyS, PowellR. Sequence of a cDNA clone encoding the Atlantic salmon alpha 1-microglobulin/bikunin protein. Gene, 147:297–298. 1994.
116.
HanssonSR, ChenY, BrodszkiJ, ChenM, Hernandez-AndradeE, InmanJM, KozhichOA, LarssonI, MarsalK, MedstrandP, XiangCC, BrownsteinMJ. Gene expression profiling of human placentas from preeclamptic and normotensive pregnancies. Mol Hum Reprod, 12:169–179. 2006.
117.
HardisonRC. A brief history of hemoglobins: plant, animal, protist, and bacteria. Proc Natl Acad Sci U S A, 93:5675–5679. 1996.
118.
HarnoisT, RousselotM, RogniauxH, ZalF. High-level production of recombinant Arenicola marina globin chains in Escherichia coli: a new generation of blood substitute. Artif Cells Blood Substit Immobil Biotechnol, 37:106–116. 2009.
119.
HarrisonGA, HumphreyKE, JonesN, BadenhopR, GuoG, ElakisG, KayeJA, TurnerRJ, GrehanM, WiltonAN, BrenneckeSP, CooperDW. A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. Am J Hum Genet, 60:1158–1167. 1997.
120.
HayashiS, OmataY, SakamotoH, HigashimotoY, HaraT, SagaraY, NoguchiM. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene, 336:241–250. 2004.
121.
Henkel-HonkeT, OleckM. Artificial oxygen carriers: a current review. AANA J, 75:205–211. 2007.
HuT, LiD, ManjulaBN, BrenowitzM, PrabhakaranM, AcharyaSA. PEGylation of Val-1(alpha) destabilizes the tetrameric structure of hemoglobin. Biochemistry, 48:608–616. 2009.
126.
HungTH, SkepperJN, Charnock-JonesDS, BurtonGJ. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res, 90:1274–1281. 2002.
127.
HvidbergV, ManieckiMB, JacobsenC, HojrupP, MollerHJ, MoestrupSK. Identification of the receptor scavenging hemopexin-heme complexes. Blood, 106:2572–2579. 2005.
128.
IdeH, ItohH, NawaY. Sequencing of cDNAs encoding alpha 1-microglobulin/bikunin of Mongolian gerbil and Syrian golden hamster in comparison with man and other species. Biochim Biophys Acta, 1209:286–292. 1994.
ImmenschuhS, NellC, IwaharaS, KatzN, Muller-EberhardU. Gene regulation of HBP 23 by metalloporphyrins and protoporphyrin IX in liver and hepatocyte cultures. Biochem Biophys Res Commun, 231:667–670. 1997.
131.
IshiiT, IwahashiH, SugataR, KidoR. Oxidation of 3-hydroxykynurenine catalyzed by methemoglobin with hydrogen peroxide. Free Radic Biol Med, 13:17–20. 1992.
132.
ItohH, TomitaM, KobayashiT, UchinoH, MaruyamaH, NawaY. Expression of inter-alpha-trypsin inhibitor light chain (bikunin) in human pancreas. J Biochem, 120:271–275. 1996.
133.
IwaharaS, SatohH, SongDX, WebbJ, BurlingameAL, NagaeY, Muller-EberhardU. Purification, characterization, and cloning of a heme-binding protein (23 kDa) in rat liver cytosol. Biochemistry, 34:13398–13406. 1995.
134.
JarolimP, LahavM, LiuSC, PalekJ. Effect of hemoglobin oxidation products on the stability of red cell membrane skeletons and the associations of skeletal proteins: correlation with a release of hemin. Blood, 76:2125–2131. 1990.
135.
JonesDP, CarlsonJL, ModyVC, CaiJ, LynnMJ, SternbergP. Redox state of glutathione in human plasma. Free Radic Biol Med, 28:625–635. 2000.
136.
JoseMD, LynnKL. Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria. Clin Nephrol, 56:172–174. 2001.
137.
KalantariH, DasDK. Physiological effects of resveratrol. Biofactors, 36:401–406. 2010.
138.
KapralovA, VlasovaII, FengW, MaedaA, WalsonK, TyurinVA, HuangZ, AnejaRK, CarcilloJ, BayirH, KaganVE. Peroxidase activity of hemoglobin-haptoglobin complexes: covalent aggregation and oxidative stress in plasma and macrophages. J Biol Chem, 284:30395–30407. 2009.
139.
KasternW, BjörckL, ÅkerströmB. Developmental and tissue-specific expression of α1-microglobulin mRNA in the rat. J Biol Chem, 261:15070–15074. 1986.
140.
KaumeyerJF, PolazziJO, KotickMP. The mRNA for a proteinase inhibitor related to the HI-30 domain of inter-alpha-trypsin inhibitor also encodes alpha-1-microglobulin (protein HC)Nucleic Acids Res, 14:7839–7850. 1986.
141.
KawaharaA, HikosakaA, SasadoT, HirotaK. Thyroid hormone-dependent repression of α1microglobulin/bikunin precursor (AMBP) gene expression during amphibian metamorphosis. Dev Genes Evol, 206:355–362. 1997.
142.
KennyLC, BroadhurstDI, DunnW, BrownM, NorthRA, McCowanL, RobertsC, CooperGJ, KellDB, BakerPN. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension, 56:741–749. 2010.
143.
KhwajaO, VolpeJJ. Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed, 93:F153–F161. 2008.
144.
Kim-ShapiroDB, SchechterAN, GladwinMT. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler Thromb Vasc Biol, 26:697–705. 2006.
145.
KimKM, PaeHO, ZhengM, ParkR, KimYM, ChungHT. Carbon monoxide induces heme oxygenase-1 via activation of protein kinase R-like endoplasmic reticulum kinase and inhibits endothelial cell apoptosis triggered by endoplasmic reticulum stress. Circ Res, 101:919–927. 2007.
146.
KristiansenM, GraversenJH, JacobsenC, SonneO, HoffmanHJ, LawSK, MoestrupSK. Identification of the haemoglobin scavenger receptor. Nature, 409:198–201. 2001.
147.
Krohne-EhrichG, SchirmerRH, Untucht-GrauR. Glutathione reductase from human erythrocytes. Isolation of the enzyme and sequence analysis of the redox-active peptide. Eur J Biochem, 80:65–71. 1977.
148.
KronborgC, VittinghusE, AllenJ, KnudsenUB. Excretion patterns of large and small proteins in pre-eclamptic pregnancies. Acta Obstet Gynecol Scand, 90:897–902. 2011.
149.
KumarS, BandyopadhyayU. Free heme toxicity and its detoxification systems in human. Toxicol Lett, 157:175–188. 2005.
150.
KuttyRK, MainesMD. Purification and characterization of biliverdin reductase from rat liver. J Biol Chem, 256:3956–3962. 1981.
151.
LambrightDG, SondekJ, BohmA, SkibaNP, HammHE, SiglerPB. The 2.0 A crystal structure of a heterotrimeric G protein. Nature, 379:311–319. 1996.
152.
LaraFA, KahnSA, da FonsecaAC, BahiaCP, PinhoJP, Graca-SouzaAV, HouzelJC, de OliveiraPL, Moura-NetoV, OliveiraMF. On the fate of extracellular hemoglobin and heme in brain. J Cereb Blood Flow Metab, 29:1109–1120. 2009.
153.
LarssonJ, AllhornM, ÅkerströmB. The lipocalin α1-microglobulin binds heme in different species. Arch Biochem Biophys, 432:196–204. 2004.
154.
LarssonJ, WingårdhK, BerggårdT, DaviesJR, LögdbergL, StrandSE, ÅkerströmB. Distribution of iodine 125-labeled α1-microglobulin in rats after intravenous injection. J Lab Clin Med, 137:165–175. 2001.
LaurellCB, NymanM. Studies on the serum haptoglobin level in hemoglobinemia and its influence on renal excretion of hemoglobin. Blood, 12:493–506. 1957.
157.
LeaverMJ, WrightJ, GeorgeSG. Conservation of the tandem arrangement of alpha 1-microglobulin/bikunin mRNA: cloning of a cDNA from plaice (Pleuronectes platessa)Comp Biochem Physiol Biochem Mol Biol, 108:275–281. 1994.
158.
LeeJW, KimSH, YoonCJ. Hemosiderin deposition on the renal cortex by mechanical hemolysis due to malfunctioning prosthetic cardiac valve: report of MR findings in two cases. J Comput Assist Tomogr, 23:445–447. 1999.
159.
LeesCC, BrownAS, HarringtonKF, BeaconHJ, MartinJF, CampbellS. A cross-sectional study of platelet volume in healthy normotensive women with bilateral uterine artery notches. Ultrasound Obstet Gynecol, 10:277–281. 1997.
160.
LevonenAL, PatelRP, BrookesP, GoYM, JoH, ParthasarathyS, AndersonPG, Darley-UsmarVM. Mechanisms of cell signaling by nitric oxide and peroxynitrite: from mitochondria to MAP kinases. Antioxid Redox Signal, 3:215–229. 2001.
LiaoJC, HeinTW, VaughnMW, HuangKT, KuoL. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci U S A, 96:8757–8761. 1999.
163.
LieRT, RasmussenS, BrunborgH, GjessingHK, Lie-NielsenE, IrgensLM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ, 316:1343–1347. 1998.
164.
LimSK, KimH, bin AliA, LimYK, WangY, ChongSM, CostantiniF, BaummanH. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood, 92:1870–1877. 1998.
165.
LindenJV, WagnerK, VoytovichAE, SheehanJ. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion, 40:1207–1213. 2000.
166.
LindqvistA, BrattT, AltieriM, KasternW, ÅkerströmB. Rat α1-microglobulin: co-expression in liver with the light chain of inter-alpha-trypsin inhibitor. Biochim Biophys Acta, 1130:63–67. 1992.
167.
LindqvistA, RouetP, SalierJP, ÅkerströmB. The α1-microglobulin/bikunin gene: characterization in mouse and evolution. Gene, 234:329–336. 1999.
168.
LindqvistA, ÅkerströmB. Bovine α1-microglobulin/bikunin. Isolation and characterization of liver cDNA and urinary α1-microglobulin. Biochim Biophys Acta, 1306:98–106. 1996.
169.
LindqvistA, ÅkerströmB. Isolation of plaice (Pleuronectes platessa) α1-microglobulin: conservation of structure and chromophore. Biochim Biophys Acta, 1430:222–233. 1999.
170.
LipsteinH, LeeCC, CrupiRS. A current concept of eclampsia. Am J Emerg Med, 21:223–226. 2003.
171.
LittleHN, NeilandsJB. Binding of haematin by human serum albumin. Nature, 188:913–915. 1960.
172.
LloydRV, HannaPM, MasonRP. The origin of the hydroxyl radical oxygen in the Fenton reaction. Free Radic Biol Med, 22:885–888. 1997.
173.
LopezC, GrubbA, MendezE. Human protein HC displays variability in its carboxyl-terminal amino acid sequence. FEBS Lett, 144:349–353. 1982.
174.
LubosE, LoscalzoJ, HandyDE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal, 15:1957–1997. 2011.
175.
LuiFE, KlugerR. Enhancing nitrite reductase activity of modified hemoglobin: bis-tetramers and their PEGylated derivatives. Biochemistry, 48:11912–11919. 2009.
176.
LuzzattoL, GianfaldoniG, NotaroR. Management of paroxysmal nocturnal haemoglobinuria: a personal view. Br J Haematol, 153:709–720. 2011.
177.
LögdbergL, WesterL. Immunocalins: a lipocalin subfamily that modulates immune and inflammatory responses. Biochim Biophys Acta, 1482:284–297. 2000.
MainesMD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol, 37:517–554. 1997.
183.
MainesMD, KappasA. Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity. Proc Natl Acad Sci U S A, 71:4293–4297. 1974.
184.
MainesMD, TrakshelGM, KuttyRK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem, 261:411–419. 1986.
185.
MaitlandK, PambaA, EnglishM, PeshuN, MarshK, NewtonC, LevinM. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clin Infect Dis, 40:538–545. 2005.
186.
MarklundSL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J, 222:649–655. 1984.
187.
MasellaR, Di BenedettoR, VariR, FilesiC, GiovanniniC. Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J Nutr Biochem, 16:577–586. 2005.
188.
MattuRK, TrevelyanJ, NeedhamEW, KhanM, AdiseshiahMA, RichterD, MurrayRG, BetteridgeDJ. Lipoprotein lipase gene variants relate to presence and degree of microalbuminuria in Type II diabetes. Diabetologia, 45:905–913. 2002.
189.
MayK, RosenlofL, OlssonMG, CentlowM, MorgelinM, LarssonI, CederlundM, RutardottirS, SiegmundW, SchneiderH, AkerstromB, HanssonSR. Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by alpha(1)-microglobulin. Placenta, 32:323–332. 2011.
190.
MayK, GrubeM, MallhotraI, LongCA, SinghS, MandilayaK, SiegmundW, FuschC, SchneiderH, KingCL. Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model. PloS One, 4:e7986. 2009.
191.
McCordJM, FridovichI. Superoxide dismutase. an enzymic function for erythrocuprein (hemocuprein)J Biol Chem, 244:6049–6055. 1969.
192.
McCoubreyWKJr., MainesMD. Domains of rat heme oxygenase-2: the amino terminus and histidine 151 are required for heme oxidation. Arch Biochem Biophys, 302:402–408. 1993.
193.
McCoubreyWKJr., MainesMD. The structure, organization and differential expression of the gene encoding rat heme oxygenase-2. Gene, 139:155–161. 1994.
194.
Melamed-FrankM, LacheO, EnavBI, SzafranekT, LevyNS, RicklisRM, LevyAP. Structure-function analysis of the antioxidant properties of haptoglobin. Blood, 98:3693–3698. 2001.
195.
MendezE, Fernandez-LunaJL, GrubbA, Leyva-CobianF. Human protein HC and its IgA complex are inhibitors of neutrophil chemotaxis. Proc Natl Acad Sci U S A, 83:1472–1475. 1986.
196.
MillerYI, ShaklaiN. Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. Biochim Biophys Acta, 1454:153–164. 1999.
NakataJ, NakahariA, KatoY, YamachiN, SatoN, YonezawaT, TakahashiC, ChikazawaS, HoriY, KanaiK, ItoN, HiguchiS, HoshiF. Molecular cloning and expression analysis of feline alpha1-microglobulin. Vet Immunol Immunopathol, 139:79–82. 2011.
201.
NatansonC, KernSJ, LurieP, BanksSM, WolfeSM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA, 299:2304–2312. 2008.
202.
NauseefWM, MetcalfJA, RootRK. Role of myeloperoxidase in the respiratory burst of human neutrophils. Blood, 61:483–492. 1983.
203.
NelzenO, BergqvistD, LindhagenA. Leg ulcer etiology—a cross sectional population study. J Vasc Surg, 14:557–564. 1991.
204.
NelzenO, BergqvistD, LindhagenA, HallbookT. Chronic leg ulcers: an underestimated problem in primary health care among elderly patients. J Epidemiol Community Health, 45:184–187. 1991.
205.
NeumannCA, CaoJ, ManevichY. Peroxiredoxin 1 and its role in cell signaling. Cell Cycle, 8:4072–4078. 2009.
206.
NielsenMJ, MoestrupSK. Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood, 114:764–771. 2009.
NielsenMJ, PetersenSV, JacobsenC, ThirupS, EnghildJJ, GraversenJH, MoestrupSK. A unique loop extension in the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex. J Biol Chem, 282:1072–1079. 2007.
209.
NoguchiM, YoshidaT, KikuchiG. Identification of the product of heme degradation catalyzed by the heme oxygenase system as biliverdin IX alpha by reversed-phase high-performance liquid chromatography. J Biochem, 91:1479–1483. 1982.
210.
NordbergJ, AllhornM, WinqvistI, ÅkerströmB, OlssonML. Quantitative and qualitative evaluation of plasma and urine α1-microglobulin in healthy donors and patients with different haemolytic disorders and haemochromatosis. Clin Chim Acta, 386:31–37. 2007.
211.
NordbergJ, ArnerES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med, 31:1287–1312. 2001.
212.
OdumL, NielsenHW. Human protein HC (alpha 1-microglobulin) and inter-alpha-trypsin inhibitor in connective tissue. Histochem J, 26:799–803. 1994.
213.
OdumL, NielsenHW. Bikunin and alpha 1-microglobulin in human zona pellucida and connective tissue. Histochem J, 29:199–203. 1997.
214.
OhsawaI, UeharaY, HashimotoS, EndoM, FujitaT, OhiH. Autoimmune hemolytic anemia occurred prior to evident nephropathy in a patient with chronic hepatitis C virus infection: case report. BMC Neprol, 29:31–37. 2003.
215.
OkudaS, NishiyamaN, SaitoH, KatsukiH. Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine. Proc Natl Acad Sci U S A, 93:12553–12558. 1996.
216.
OlssonMG, AllhornM, LarssonJ, CederlundM, LundqvistK, SchmidtchenA, SorensenOE, MörgelinM, ÅkerströmB. Up-regulation of A1M/α1-microglobulin in skin by heme and reactive oxygen species gives protection from oxidative damage. PLoS One, 6:e27505. 2011.
217.
OlssonMG, AllhornM, OlofssonT, ÅkerströmB. Up-regulation of α1-microglobulin by hemoglobin and reactive oxygen species in hepatoma and blood cell lines. Free Radic Biol Med, 42:842–851. 2007.
218.
OlssonMG, CentlowM, RutardóttirS, StenforsI, LarssonJ, Hosseini-MaafB, OlssonML, HanssonSR, ÅkerströmB. Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger α1-microglobulin in preeclampsia. Free Radic Biol Med, 48:284–291. 2010.
219.
OlssonMG, NilssonEJ, RutardottirS, PaczesnyJ, PallonJ, ÅkerströmB. Bystander cell death and stress response is inhibited by the radical scavenger α1-microglobulin in irradiated cell cultures. Radiat Res, 174:590–600. 2010.
220.
OlssonMG, OlofssonT, TapperH, ÅkerströmB. The lipocalin α1-microglobulin protects erythroid K562 cells against oxidative damage induced by heme and reactive oxygen species. Free Radic Res, 42:725–736. 2008.
221.
OtterbeinLE, MantellLL, ChoiAM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol, 276:L688–L694. 1999.
222.
PadayattySJ, KatzA, WangY, EckP, KwonO, LeeJH, ChenS, CorpeC, DuttaA, DuttaSK, LevineM. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr, 22:18–35. 2003.
223.
PageEW. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol, 37:291–293. 1939.
224.
PaoliM, AndersonBF, BakerHM, MorganWT, SmithA, BakerEN. Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains. Nat Struct Biol, 6:926–931. 1999.
225.
ParkJ, ChaDH, LeeSJ, KimYN, KimYH, KimKP. Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis. Exp Mol Med, 43:427–435. 2011.
226.
PawlakD, PawlakK, MalyszkoJ, MysliwiecM, BuczkoW. Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. Int Urol Nephrol, 33:399–404. 2001.
PoliG, LeonarduzziG, BiasiF, ChiarpottoE. Oxidative stress and cell signalling. Curr Med Chem, 11:1163–1182. 2004.
230.
PolticelliF, BocediA, MinerviniG, AscenziP. Human haptoglobin structure and function—a molecular modelling study. FEBS J, 275:5648–5656. 2008.
231.
PolyzosNP, MauriD, TsappiM, TziorasS, KamposiorasK, CortinovisI, CasazzaG. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv, 62:202–206. 2007.
232.
QuiochoFA. Atomic structures of periplasmic binding proteins and the high-affinity active transport systems in bacteria. Philos Trans R Soc Lond B Biol Sci, 326:341–351discussion 351–3521990.
233.
RajagopalA, RaoAU, AmigoJ, TianM, UpadhyaySK, HallC, UhmS, MathewMK, FlemingMD, PawBH, KrauseM, HamzaI. Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins. Nature, 453:1127–1131. 2008.
234.
RajuVS, McCoubreyWKJr., MainesMD. Regulation of heme oxygenase-2 by glucocorticoids in neonatal rat brain: characterization of a functional glucocorticoid response element. Biochim Biophys Acta, 1351:89–104. 1997.
235.
ReederBJ. The redox activity of hemoglobins: from physiologic functions to pathologic mechanisms. Antioxid Redox Signal, 13:1087–1123. 2010.
236.
ReederBJ, CutruzzalaF, BigottiMG, HiderRC, WilsonMT. Tyrosin as a redox-active center in electron transfer to ferryl heme in globins. Free Radic Biol Med, 44:274–283. 2008.
237.
ReederBJ, GreyM, Silaghi-DumitrescuRL, SvistunenkoDA, BulowL, CooperCE, WilsonMT. Tyrosine residues as redox cofactors in human hemoglobin: implications for engineering nontoxic blood substitutes. J Biol Chem, 283:30780–30787. 2008.
238.
ReganRF, PanterSS. Neurotoxicity of hemoglobin in cortical cell culture. Neurosci Lett, 153:219–222. 1993.
RobertsJM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol, 16:5–15. 1998.
241.
RobertsJM, CooperDW. Pathogenesis and genetics of pre-eclampsia. Lancet, 357:53–56. 2001.
242.
RobertsJM, HubelCA. Is oxidative stress the link in the two-stage model of pre-eclampsia?Lancet, 354:788–789. 1999.
243.
RobertsJM, HubelCA. The two stage model of preeclampsia: variations on the theme. Placenta, 30,Suppl A:S32–S37. 2009.
244.
RobertsJM, MyattL, SpongCY, ThomEA, HauthJC, LevenoKJ, PearsonGD, WapnerRJ, VarnerMW, ThorpJMJr., MercerBM, PeacemanAM, RaminSM, CarpenterMW, SamuelsP, SciscioneA, HarperM, SmithWJ, SaadeG, SorokinY, AndersonGB. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med, 362:1282–1291. 2010.
245.
RobertsJM, TaylorRN, MusciTJ, RodgersGM, HubelCA, McLaughlinMK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol, 161:1200–1204. 1989.
246.
RocheCJ, MalashkevichV, BalazsTC, DantskerD, ChenQ, MoreiraJ, AlmoSC, FriedmanJM, HirschRE. Structural and functional studies indicating altered redox properties of hemoglobin E: implications for production of bioactive nitric oxide. J Biol Chem, 286:23452–23466. 2011.
247.
RosenfeldM, SurgenorDM. Methemalbumin, interaction between human serum albumin and ferriprotoporphyrin IX. J Biol Chem, 183:663–677. 1950.
248.
RotherRP, BellL, HillmenP, GladwinMT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA, 293:1653–1662. 2005.
249.
RouetP, RaguenezG, RuminyP, SalierJP. An array of binding sites for hepatocyte nuclear factor 4 of high and low affinities modulates the liver-specific enhancer for the human alpha1-microglobulin/bikunin precursor. Biochem J, 334,Pt 3:577–584. 1998.
250.
RouetP, RaguenezG, TroncheF, YanivM, N'GuyenC, SalierJP. A potent enhancer made of clustered liver-specific elements in the transcription control sequences of human alpha 1-microglobulin/bikunin gene. J Biol Chem, 267:20765–20773. 1992.
251.
RyterSW, ChoiAM. Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models. Antioxid Redox Signal, 7:80–91. 2005.
252.
SakaiH, TakeokaS, KobayashiK. Gas bioengineering using hemoglobin-vesicles for versatile clinical applications. Curr Pharm Des, 17:2352–2359. 2011.
253.
SalaA, CampagnoliM, PeraniE, RomanoA, LaboS, MonzaniE, MinchiottiL, GallianoM. Human alpha-1-microglobulin is covalently bound to kynurenine-derived chromophores. J Biol Chem, 279:51033–51041. 2004.
254.
SalierJP, RouetP, RaguenezG, DaveauM. The inter-alpha-inhibitor family: from structure to regulation. Biochem J, 315,Pt 1:1–9. 1996.
255.
SalierJP, SimonD, RouetP, RaguenezG, MuscatelliF, GebhardW, GuenetJL, MatteiMG. Homologous chromosomal locations of the four genes for inter-alpha-inhibitor and pre-alpha-inhibitor family in human and mouse: assignment of the ancestral gene for the lipocalin superfamily. Genomics, 14:83–88. 1992.
256.
SalierJP, VergaV, DolyJ, Diarra-MehrpourM, EricksonRP. The genes for the inter-alpha-inhibitor family share a homologous organization in human and mouse. Mamm Genome, 2:233–239. 1992.
257.
SanoS, SanoT, MorishimaI, ShiroY, MaedaY. On the mechanism of the chemical and enzymic oxygenations of alpha-oxyprotohemin IX to Fe.biliverdin IX alpha. Proc Natl Acad Sci U S A, 83:531–535. 1986.
258.
SantinM, CannasM. Collagen-bound alpha1-microglobulin in normal and healed tissues and its effect on immunocompetent cells. Scand J Immunol, 50:289–295. 1999.
259.
SazamaK. Transfusion errors: scope of the problem, consequences, and solutions. Curr Hematol Rep, 2:518–521. 2003.
260.
SchaerCA, SchoedonG, ImhofA, KurrerMO, SchaerDJ. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ Res, 99:943–950. 2006.
261.
SchmittTH, FrezzattiWAJr., SchreierS. Hemin-induced lipid membrane disorder and increased permeability: a molecular model for the mechanism of cell lysis. Arch Biochem Biophys, 307:96–103. 1993.
262.
SchneiderH, HuchA. Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentation. Contrib Gynecol Obstet, 13:40–47. 1985.
SchroederBM. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. Am Fam Physician, 66:330–331. 2002.
265.
SearsDA. Disposal of plasma heme in normal man and patients with intravascular hemolysis. J Clin Invest, 49:5–14. 1970.
266.
SeidahNG, MayerG, ZaidA, RousseletE, NassouryN, PoirierS, EssalmaniR, PratA. The activation and physiological functions of the proprotein convertases. Int J Biochem Cell Biol, 40:1111–1125. 2008.
267.
SeonBK, PressmanD. Unique human glycoprotein, alpha1-microglycoprotein: isolation from the urine of a cancer patient and its characterization. Biochemistry, 17:2815–2821. 1978.
SmithTF, GaitatzesC, SaxenaK, NeerEJ. The WD repeat: a common architecture for diverse functions. Trends Biochem Sci, 24:181–185. 1999.
274.
SpringerTA. Folding of the N-terminal, ligand-binding region of integrin alpha-subunits into a beta-propeller domain. Proc Natl Acad Sci U S A, 94:65–72. 1997.
275.
StainsbyD, JonesH, AsherD, AtterburyC, BoncinelliA, BrantL, ChapmanCE, DavisonK, GerrardR, GrayA, KnowlesS, LoveEM, MilkinsC, McClellandDB, NorfolkDR, SoldanK, TaylorC, RevillJ, WilliamsonLM, CohenH. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev, 20:273–282. 2006.
276.
SteinbergMH. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge University Press: Cambridge, 2001.
277.
StevensJM. Gynaecology from ancient Egypt: the papyrus Kahun: a translation of the oldest treatise on gynaecology that has survived from the ancient world. Med J Aust, 2:949–952. 1975.
278.
StillmanIE, KarumanchiSA. The glomerular injury of preeclampsia. J Am Soc Nephrol, 18:2281–2284. 2007.
279.
StockerR, YamamotoY, McDonaghAF, GlazerAN, AmesBN. Bilirubin is an antioxidant of possible physiological importance. Science, 235:1043–1046. 1987.
280.
StrevensH, Wide-SwenssonD, HansenA, HornT, IngemarssonI, LarsenS, WillnerJ, OlsenS. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol, 110:831–836. 2003.
281.
SundaramM, SivaprasadaraoA, AaltenDM, FindlayJB. Expression, characterization and engineered specificity of rat epididymal retinoic acid-binding protein. Biochem J, 334,Pt 1:155–160. 1998.
282.
SuttonHC, WinterbournCC. On the participation of higher oxidation states of iron and copper in Fenton reactions. Free Radic Biol Med, 6:53–60. 1989.
283.
TakagiT, TakagiK, KawaiT. Complete amino acid sequence of human alpha 1-microglobulin. Biochem Biophys Res Commun, 98:997–1001. 1981.
284.
TalosiG, EndreffyE, TuriS, NemethI. Molecular and Genetic Aspects of Preeclampsia: State of the Art. Mol Genet Metab, 71:565–572. 2000.
285.
TamSC, WongJT. Impairment of renal function by stroma-free hemoglobin in rats. J Lab Clin Med, 111:189–193. 1988.
286.
TavakkolA. Molecular cloning of porcine alpha 1-microglobulin/HI-30 reveals developmental and tissue-specific expression of two variant messenger ribonucleic acids. Biochim Biophys Acta, 1088:47–56. 1991.
287.
TavazziD, TaherA, CappelliniMD. Red blood cell enzyme disorders: an overview. Pediatr Ann, 37:303–310. 2008.
288.
TejlerL, ErikssonS, GrubbA, AstedtB. Production of protein HC by human fetal liver explants. Biochim Biophys Acta, 542:506–514. 1978.
289.
TejlerL, GrubbAO. A complex-forming glycoprotein heterogeneous in charge and present in human plasma, urine, and cerebrospinal fluid. Biochim Biophys Acta, 439:82–94. 1976.
290.
TenhunenR, MarverHS, SchmidR. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A, 61:748–755. 1968.
291.
TenhunenR, MarverHS, SchmidR. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem, 244:6388–6394. 1969.
292.
ter HaarE, MusacchioA, HarrisonSC, KirchhausenT. Atomic structure of clathrin: a beta propeller terminal domain joins an alpha zigzag linker. Cell, 95:563–573. 1998.
ThuvesonM, FriesE. Intracellular proteolytic processing of the heavy chain of rat pre-alpha-inhibitor. The COOH-terminal propeptide is required for coupling to bikunin. J Biol Chem, 274:6741–6746. 1999.
295.
TolosanoE, AltrudaF. Hemopexin: structure, function, and regulation. DNA Cell Biol, 21:297–306. 2002.
296.
TrakshelGM, KuttyRK, MainesMD. Purification and characterization of the major constitutive form of testicular heme oxygenase. The noninducible isoform. J Biol Chem, 261:11131–11137. 1986.
297.
TreloarSA, CooperDW, BrenneckeSP, GrehanMM, MartinNG. An Australian twin study of the genetic basis of preeclampsia and eclampsia. Am J Obstet Gynecol, 184:374–381. 2001.
298.
TripetteJ, AlexyT, Hardy-DessourcesMD, MougenelD, BeltanE, ChalabiT, ChoutR, Etienne-JulanM, HueO, MeiselmanHJ, ConnesP. Red blood cell aggregation, aggregate strength and oxygen transport potential of blood are abnormal in both homozygous sickle cell anemia and sickle-hemoglobin C disease. Haematologica, 94:1060–1065. 2009.
299.
TsemakhovichVA, BammVV, ShaklaiM, ShaklaiN. Vascular damage by unstable hemoglobins: the role of heme-depleted globin. Arch Biochem Biophys, 436:307–315. 2005.
300.
VandegriffKD, YoungMA, LohmanJ, BellelliA, SamajaM, MalavalliA, WinslowRM. CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br J Pharmacol, 154:1649–1661. 2008.
301.
VanlairCF, MasiusJR. De la microcythemie. Bull Acad Med Belg 3e Ser, 5:515–613. 1871.
302.
VaughnMW, HuangKT, KuoL, LiaoJC. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem, 275:2342–2348. 2000.
303.
VazquezS, GarnerB, SheilMM, TruscottRJ. Characterisation of the major autoxidation products of 3-hydroxykynurenine under physiological conditions. Free Radic Res, 32:11–23. 2000.
304.
VichinskyE. Hemoglobin E syndromes. Hematol Am Soc Hematol Educ Program, 79–83. 2007.
305.
VileGF, Basu-ModakS, WaltnerC, TyrrellRM. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc Natl Acad Sci U S A, 91:2607–2610. 1994.
306.
VilloutreixBO, ÅkerströmB, LindqvistA. Structural model of human α1-microglobulin: proposed scheme for the interaction with the Gla domain of anticoagulant protein C. Blood Coagul Fibrinolysis, 11:261–275. 2000.
307.
VincentC, BouicP, RevillardJP. Characterization of rat alpha 1 microglobulin. Biochem Biophys Res Commun, 116:180–188. 1983.
308.
VohrBR, WrightLL, DusickAM, MeleL, VerterJ, SteichenJJ, SimonNP, WilsonDC, BroylesS, BauerCR, Delaney-BlackV, YoltonKA, FleisherBE, PapileLA, KaplanMD. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993–1994. Pediatrics, 105:1216–1226. 2000.
309.
VolpeJJ. Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev, 7:56–64. 2001.
310.
WagenerFA, EggertA, BoermanOC, OyenWJ, VerhofstadA, AbrahamNG, AdemaG, van KooykY, de WitteT, FigdorCG. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood, 98:1802–1811. 2001.
311.
WalterPB, FungEB, KillileaDW, JiangQ, HudesM, MaddenJ, PorterJ, EvansP, VichinskyE, HarmatzP. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol, 135:254–263. 2006.
WesterL, FastJ, LabudaT, CedervallT, WingårdhK, OlofssonT, ÅkerströmB. Carbohydrate groups of α1-microglobulin are important for secretion and tissue localization but not for immunological properties. Glycobiology, 10:891–900. 2000.
314.
WesterL, MichaelssonE, HolmdahlR, OlofssonT, ÅkerströmB. Receptor for α1-microglobulin on T lymphocytes: inhibition of antigen-induced interleukin-2 production. Scand J Immunol, 48:1–7. 1998.
315.
WhitelawA, JaryS, KmitaG, WroblewskaJ, Musialik-SwietlinskaE, ManderaM, HuntL, CarterM, PopleI. Randomized trial of drainage, irrigation and fibrinolytic therapy for premature infants with posthemorrhagic ventricular dilatation: developmental outcome at 2 years. Pediatrics, 125:e852–e858. 2010.
WicherKB, FriesE. Haptoglobin, a hemoglobin-binding plasma protein, is present in bony fish and mammals but not in frog and chicken. Proc Natl Acad Sci U S A, 103:4168–4173. 2006.
WilkinsonLS, BunkerC, EdwardsJC, ScurrJH, SmithPD. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg, 17:669–675. 1993.
YoshidaT, TakahashiS, KikuchiG. Partial purification and reconstitution of the heme oxygenase system from pig spleen microsomes. J Biochem, 75:1187–1191. 1974.
325.
YuB, BlochKD, ZapolWM. Hemoglobin-based red blood cell substitutes and nitric oxide. Trends Cardiovasc Med, 19:103–107. 2009.
326.
ZamboniP, IzzoM, TognazzoS, CarandinaS, De PalmaM, CatozziL, CaggiatiA, ScapoliG, GemmatiD. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. Free Radic Biol Med, 40:1869–1873. 2006.
327.
ZamboniP, ScapoliG, LanzaraV, IzzoM, FortiniP, LegnaroR, PalazzoA, TognazzoS, GemmatiD. Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers. Dermatol Surg, 31:644–649discussion 6492005.
328.
ZamboniP, TognazzoS, IzzoM, PancaldiF, ScapoliGL, LiboniA, GemmatiD. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. J Vasc Surg, 42:309–314. 2005.
329.
ZhangN, PalmerAF. Polymerization of human hemoglobin using the crosslinker 1,11-bis(maleimido)triethylene glycol for use as an oxygen carrier. Biotechnol Prog, 26:1481–1485. 2010.
330.
ZhouH, BeeversCS, HuangS. The targets of curcumin. Curr Drug Targets, 12:332–347. 2011.
331.
ZhouML, ShiJX, HangCH, ZhangFF, GaoJ, YinHX. Expression of Toll-like receptor 4 in the brain in a rabbit experimental subarachnoid haemorrhage model. Inflamm Res, 56:93–97. 2007.
332.
ZhouZ, KangYJ. Cellular and subcellular localization of catalase in the heart of transgenic mice. J Histochem Cytochem, 48:585–594. 2000.
333.
ÅkerströmB. Tissue distribution of guinea pig α1-microglobulin. Cell Mol Biol, 29:489–495. 1983.
334.
ÅkerströmB. Immunological analysis of α1-microglobulin in different mammalian and chicken serum. α1-Microglobulin is 5–8 kilodaltons larger in primates. J Biol Chem, 260:4839–4844. 1985.
335.
ÅkerströmB, BerggårdI. Guinea-pig alpha 1 microglobulin. Isolation and properties in comparison with human α1- microglobulin. Eur J Biochem, 101:215–223. 1979.
336.
ÅkerströmB, BrattT, EnghildJJ. Formation of the α1-microglobulin chromophore in mammalian and insect cells: a novel post-translational mechanism?FEBS Lett, 362:50–54. 1995.
ÅkerströmB, LögdbergL, Babiker-MohamedH, LohmanderS, RaskL. Structural relationship between α1-microglobulin from man, guinea-pig, rat and rabbit. Eur J Biochem, 170:143–148. 1987.
341.
ÅkerströmB, MaghzalGJ, WinterbournCC, KettleAJ. The lipocalin α1-microglobulin has radical scavenging activity. J Biol Chem, 282:31493–31503. 2007.
